| ★ | Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B | | 521 | Estados Unidos | |
| 7 | ACIP Removes Universal Hepatitis B Vaccine Recommendation - Major Policy Shift! | aphapharmacists @aphapharmacists | — | — | 84 |
| 8 | The end of Rx Report? | aphapharmacists @aphapharmacists | — | — | 84 |
| 16 | Understanding Disease Progression in MS - presented by Aaron Boster, MD from rural Virginia | The MS Views and News Learning Channel @msviewsandnews | 1.5K | Estados Unidos | 84 |
| 3 | Inside the VESPER-3 Results: Berobenatide's Weight Loss Potential | | 839 | Estados Unidos | 86 |
| 11 | Hepatitis B y C: Tratamientos Antivirales y Curas Efectivas #shorts | Tu Salud Tu Familia @tusaludtufamilia | 639 | Estados Unidos | 84 |
| 18 | Vacunación para Hepatitis B: un caso de éxito en riesgo de un gran retroceso | Lista de Espera, el podcast de la salud @listadeesperapodcast | 585 | Chile | 84 |
| 20 | GDF2026 - Updates on Nitrosamines/ Nitrosamine Mitigation Strategies for Pharmaceuticals | U.S. Food and Drug Administration @us_fda | 409 | Estados Unidos | 84 |
| 10 | GDF2026 - Q&A Discussion Panel Eight | U.S. Food and Drug Administration @us_fda | 298 | Estados Unidos | 84 |
| 2 | Berobenatide Monthly GLP-1 Injectable Shows Promise for Weight Loss | | 250 | Estados Unidos | 86 |
| 13 | Provider Connections: Dr. Nora Bennani on Relapsed Refractory T-Cell Lymphoma | | 208 | Estados Unidos | 84 |
| 6 | What Comes Next for PORT-77 as It Heads Toward Phase 2b/3? | | 196 | Estados Unidos | 85 |
| 5 | GDF2026 - Q&A Discussion Panel Four and Day One Closing | U.S. Food and Drug Administration @us_fda | 187 | Estados Unidos | 85 |
| 4 | GDF2026 - Bioequivalence (BE) Recommendations for Bridging Pre- and Post-Mitigation Formulations | U.S. Food and Drug Administration @us_fda | 160 | Estados Unidos | 85 |
| 9 | GDF2026 - Q&A Discussion Panel Three | U.S. Food and Drug Administration @us_fda | 72 | Estados Unidos | 84 |
| 15 | Looking Beyond ALP Response in PBC With Saroglitazar, With Raj Vuppalanchi, MD | | 68 | Estados Unidos | 84 |
| 1 | Liver Lineup | Hepatitis D: Testing Gaps, Bulevirtide, and What's Next in the Pipeline | | 33 | Estados Unidos | 90 |
| 17 | GDF2026 - Q&A Discussion Panel Five | U.S. Food and Drug Administration @us_fda | 29 | Estados Unidos | 84 |
| 19 | 10.2025 Part 2 A Clinicians Perspective on HRT and Breast Cancer | aphapharmacists @aphapharmacists | 24 | — | 84 |
| 14 | Falling in & out of love with pharma at Next Pharma Summit | Brandcast Health @brandcasthealthuk | 16 | — | 84 |